$Fermentation, fractionation and purification of streptokinase by chemical reduction method$

Fermentation, fractionation and purification of streptokinase by chemical reduction method

Background and Objectives: Streptokinase is used clinically as an intravenous thrombolytic agent for the treatment of acute myocardial infarction and is commonly prepared from cultures of Streptococcus equisimilis strain H46A. The objective of the present study was the production of streptokinase fr...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Z Karimi, M Babashamsi, E Asgarani, M Niakan, A Salimi
Natura:	Articolo
Lingua:	English
Pubblicazione:	Tehran University of Medical Sciences 2011-03-01
Serie:	Iranian Journal of Microbiology
Soggetti:	Streptokinase Fermentation Purification Chemical Reduction
Accesso online:	https://ijm.tums.ac.ir/index.php/ijm/article/view/84

Documenti analoghi

Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity
di: Ehab El-Dabaa, et al.
Pubblicazione: (2022-05-01)

Enhanced Production Of Streptokinase By Chemical Mutagenesis Of Streptococcus agalactiae EBL-20
di: Arooj Arshad, et al.
Pubblicazione: (2019-05-01)

DETECTION OF SK GENE ENCODING STREPTOKINASE IN DIFFERENT PATHOGENIC BACTERIAL ISOLATES
di: HARITH K. BUNIYA
Pubblicazione: (2013-08-01)

PLASMINOGEN ACTIVATION BY LOW MOLECULAR WEIGHT STREPTOKINASE AND FIBRIN EFFECT
di: E. I. Yusova
Pubblicazione: (2014-06-01)

Evaluation of Streptokinase Production Potential by Group C Streptococcal Strain H46A in Batch Culture and Bactericidal Effect of Hexyl Resorcinol
di: MR Nejadmoghaddam,, et al.
Pubblicazione: (2009-10-01)

Comparing Two Nomograms of Heparin Dosing after Receiving Streptokinase
di: M Modares Mosadegh, et al.
Pubblicazione: (2015-10-01)

Fibrinolytic Activity of Recombinant Mutant Streptokinase
di: Mahboobeh Mobarrez, et al.
Pubblicazione: (2015-04-01)

Expression of Recombinant Streptokinase from Streptococcus Pyogenes and Its Reaction with Infected Human and Murine Sera
di: Neda Molaee, et al.
Pubblicazione: (2013-09-01)

Bolus streptokinase administration in acute myocardial infarction: features of hypotensive reaction
di: V. A. Stolyarov, et al.
Pubblicazione: (2005-04-01)

Streptokinase‐Induced Serum Sickness: A Case Report
di: Bibek Shrestha, et al.
Pubblicazione: (2024-12-01)

Intrapleural Streptokinase in Management of Multiloculated Uraemic Pleural Effusion- A case report
di: Rawat J, et al.
Pubblicazione: (2006-01-01)

Safety and efficacy of streptokinase in multiloculated pleural effusion in pediatric population
di: Akhtar Reza, et al.
Pubblicazione: (2022-01-01)

Using streptokinase for pleural adhesiolysis in sonographically septated pleural effusion
di: Amany Omar, et al.
Pubblicazione: (2015-10-01)

Massive hemothorax following administration of intrapleural streptokinase
di: Chai Feng, et al.
Pubblicazione: (2011-01-01)

Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic /Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study
di: Maryam Rafipour, et al.
Pubblicazione: (2020-01-01)

Treatment of femoral artery thrombosis with streptokinase and heparin after cardiac catheterization
di: Hojjat Mortezaiyan, et al.
Pubblicazione: (2014-01-01)

Management of Prosthetic Tricuspid Valve Thrombosis with Streptokinase
di: Azizullah, et al.
Pubblicazione: (2023-12-01)

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen
di: Ahmed Bendary, et al.
Pubblicazione: (2017-12-01)

A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients
di: Nur-A-Farhana Islam, et al.
Pubblicazione: (2008-06-01)

A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients
di: Md. Anup Rahman Chowdhury, et al.
Pubblicazione: (2008-04-01)

Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase
di: Hossein Saidi, et al.
Pubblicazione: (2013-12-01)

Is accelerated idioventricular rhythm a good marker for reperfusion after streptokinase?
di: Ashar Khan, et al.
Pubblicazione: (2016-05-01)

Streptokinase Adverse Reactions: A Review of Iranian Literature
di: Ava Mansouri, et al.
Pubblicazione: (2015-10-01)

Site-Directed Mutation, Cloning and Expression of Streptokinase for Producing a New Suitable Molecule for PEGylation
di: Somayeh Bagheri, et al.
Pubblicazione: (2016-06-01)

Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial
di: Mojtaba Salarifar, et al.
Pubblicazione: (2009-01-01)

Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial
di: Navid Paydari, et al.
Pubblicazione: (2009-03-01)

Labeling of the Recombinant Streptokinase Using Iodine-131 as a New Thrombolytic Agent
di: I. Daruwati, et al.
Pubblicazione: (2012-12-01)

The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme
di: Deep Chandh Raja, et al.
Pubblicazione: (2017-09-01)

Cloning and expression of truncated and intact streptokinase molecules in E.coli and evaluation of their biological activities
di: Reza Arabi, et al.
Pubblicazione: (2010-05-01)

Analysis of five streptokinase formulations using the euglobulin lysis test and the plasminogen activation assay
di: Couto L.T., et al.
Pubblicazione: (2004-01-01)

An Uncommon Complication of Streptokinase: Large Spontaneous Iliopsoas Hematoma
di: Raheleh Aliabadi, et al.
Pubblicazione: (2017-08-01)

Comparison of Streptokinase Activity from Streptococcus mutans using Different Substrates
di: Muhammad Anjum Zia*, Rana Faisal, Rao Zahid Abbas1, Gull-e-Faran, Muhammad Kashif Saleemi2 and Junaid Ali Khan3
Pubblicazione: (2013-01-01)

The comparison of streptokinase, an old agent, versus reteplase for the re-tunnellisation of blocked cuffed haemodialysis catheter
di: Saroukhani Abbas, et al.
Pubblicazione: (2024-01-01)

Initial evidence of safety and clinical effect of recombinant streptokinase suppository in acute hemorrhoidal disease. Open, proof-of-concept, pilot trial
di: Liván Quintero, et al.

Streptokinase is dispensable in Streptococcus dysgalactiae subspecies equisimilis infections of human dendritic cells
di: Katharina E. Folz, et al.
Pubblicazione: (2025-01-01)

STREPTOKINASE EFFICACY IN MYOCARDIAL INFARCTION MANAGEMENT: IS IT RELATED TO SERUM ANTISTREPTOKINASE ANTIBODY TITER
di: H SHEMIRANI, et al.
Pubblicazione: (2000-06-01)

Streptokinase in the Treatment of Venous Sinus Thrombosis: A Case Report
di: Yuan-Han Yang, et al.
Pubblicazione: (2003-08-01)

Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study
di: Maryam Rafipour, et al.
Pubblicazione: (2020-01-01)

Efficacy of video-assisted thoracoscopic surgery versus intrapleural streptokinase for treatment of parapneumonic empyema with multiloculation and septation
di: Reza Ershadi, et al.
Pubblicazione: (2022-06-01)

The effects of various streptokinase thrombolysis regimens on coagulation hemostasis and fibrinolysis in acute myocardial infarction
di: Ya. L. Gabinsky, et al.
Pubblicazione: (2006-12-01)